Literature DB >> 29352029

Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression.

Annabel E L Walsh1,2, Michael Browning3,2, Wayne C Drevets4, Maura Furey4, Catherine J Harmer5,2.   

Abstract

Antidepressants remediate negative biases in emotional processing early in treatment, prior to mood improvement. However, the effects on reward processing potentially relevant to the treatment of anhedonia are less clear. Here we investigate the early and sustained effects of the dopamine and noradrenaline reuptake inhibitor bupropion on behavioural measures of emotional and reward processing in currently depressed individuals. Forty-six currently depressed patients and 42 healthy controls participated in a repeated measures study, during which open-label bupropion was administered to only the patient group over a six week period without a placebo group. All participants completed the Emotional Test Battery and a probabilistic instrumental learning task at week 0, week 2 and week 6. Currently depressed patients displayed negative biases in emotional processing and blunted response bias for high-probability wins compared to the healthy controls at baseline. Bupropion was found to reduce the negative biases in emotional processing early in treatment, including a significant decrease in the percentage misclassification of other face emotions as sad and the number of negative self-referent words falsely recalled between baseline and week 2. Conversely, bupropion was found to initially further reduce the response bias for high-probability wins between baseline and week 2. This effect reversed with six weeks' bupropion treatment and reward processing was normalized compared to the healthy controls. Early in treatment, bupropion acts to reduce negative biases in emotional processing but exacerbates impaired reward processing. The beneficial actions of bupropion on reward processing then occur later in treatment. Such dissociation in the temporal effects of bupropion on emotional and reward processing has implications for the treatment of the different symptom domains of negative affect and anhedonia in depression.This article is part of a discussion meeting issue 'Of mice and mental health: facilitating dialogue between basic and clinical neuroscientists'.
© 2018 The Author(s).

Entities:  

Keywords:  bupropion; depression; dopamine; emotional processing; reward

Mesh:

Substances:

Year:  2018        PMID: 29352029      PMCID: PMC5790828          DOI: 10.1098/rstb.2017.0030

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  47 in total

1.  Acute SSRI administration affects the processing of social cues in healthy volunteers.

Authors:  C J Harmer; Z Bhagwagar; D I Perrett; B A Völlm; P J Cowen; G M Goodwin
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.

Authors:  Richard Tranter; Diana Bell; Petra Gutting; Catherine Harmer; David Healy; Ian M Anderson
Journal:  J Affect Disord       Date:  2009-02-27       Impact factor: 4.839

4.  Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

Authors:  G B Cassano; M C Jori
Journal:  Int Clin Psychopharmacol       Date:  2002-01       Impact factor: 1.659

5.  Development and validation of brief measures of positive and negative affect: the PANAS scales.

Authors:  D Watson; L A Clark; A Tellegen
Journal:  J Pers Soc Psychol       Date:  1988-06

Review 6.  Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings.

Authors:  Jukka M Leppänen
Journal:  Curr Opin Psychiatry       Date:  2006-01       Impact factor: 4.741

7.  Enhanced neural response to anticipation, effort and consummation of reward and aversion during bupropion treatment.

Authors:  Z Dean; S Horndasch; P Giannopoulos; C McCabe
Journal:  Psychol Med       Date:  2016-05-18       Impact factor: 7.723

8.  Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.

Authors:  Ciara McCabe; Zevic Mishor; Philip J Cowen; Catherine J Harmer
Journal:  Biol Psychiatry       Date:  2009-12-24       Impact factor: 13.382

9.  Highly neurotic never-depressed students have negative biases in information processing.

Authors:  Stella W Y Chan; Guy M Goodwin; Catherine J Harmer
Journal:  Psychol Med       Date:  2007-05-10       Impact factor: 7.723

10.  A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers.

Authors:  Annabel E L Walsh; Nathan T M Huneke; Randi Brown; Michael Browning; Phil Cowen; Catherine J Harmer
Journal:  Front Psychiatry       Date:  2018-10-16       Impact factor: 4.157

View more
  9 in total

1.  Of mice and mental health: facilitating dialogue and seeing further.

Authors:  Amy L Milton; Emily A Holmes
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

2.  Bupropion increases activation in nucleus accumbens during anticipation of monetary reward.

Authors:  Yumiko Ikeda; Takuya Funayama; Amane Tateno; Haruhisa Fukayama; Yoshiro Okubo; Hidenori Suzuki
Journal:  Psychopharmacology (Berl)       Date:  2019-07-24       Impact factor: 4.530

3.  Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression.

Authors:  Annabel E L Walsh; Michael Browning; Wayne C Drevets; Maura Furey; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

4.  No antidepressant-like acute effects of bright light on emotional information processing in healthy volunteers.

Authors:  Alexander Kaltenboeck; Tereza Ruzickova; Veronika Breunhölder; Tarek Zghoul; Philip J Cowen; Catherine J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.530

5.  PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Authors:  Sheena Kristine Au-Yeung; James Griffiths; Sophie Roberts; Chloe Edwards; Ly-Mee Yu; Rafal Bogacz; Jennifer Rendell; Mary-Jane Attenburrow; Stuart Watson; Fiona Chan; Andrea Cipriani; Anthony Cleare; Catherine J Harmer; David Kessler; Jonathan Evans; Glyn Lewis; Ilina Singh; Judit Simon; Paul J Harrison; Phil Cowen; Milensu Shanyinde; John Geddes; Michael Browning
Journal:  Evid Based Ment Health       Date:  2021-11-22

6.  An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers.

Authors:  Riccardo De Giorgi; Alice M G Quinton; Shona Waters; Philip J Cowen; Catherine J Harmer
Journal:  Psychopharmacology (Berl)       Date:  2022-05-05       Impact factor: 4.415

7.  A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers.

Authors:  Annabel E L Walsh; Nathan T M Huneke; Randi Brown; Michael Browning; Phil Cowen; Catherine J Harmer
Journal:  Front Psychiatry       Date:  2018-10-16       Impact factor: 4.157

8.  Modulation of anterior cingulate cortex reward and penalty signalling in medication-naive young-adult subjects with depressive symptoms following acute dose lurasidone.

Authors:  Selina A Wolke; Mitul A Mehta; Owen O'Daly; Fernando Zelaya; Nada Zahreddine; Hanna Keren; Georgia O'Callaghan; Allan H Young; Ellen Leibenluft; Daniel S Pine; Argyris Stringaris
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

9.  The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study.

Authors:  Riccardo De Giorgi; Marieke Martens; Nicola Rizzo Pesci; Philip J Cowen; Catherine J Harmer
Journal:  J Psychopharmacol       Date:  2021-12       Impact factor: 4.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.